MiniMed director receives 13,889 restricted stock units

MiniMed Group, Inc. director Timothy A. Wicks reported an acquisition of 13,889 shares of common stock through a grant of restricted stock units.

Rhea-AI Filing Summary

MiniMed Group, Inc. director Timothy A. Wicks reported an acquisition of 13,889 shares of common stock through a grant of restricted stock units. These units vest on the one-year anniversary of the grant date rather than being immediately transferable.

After this award, Wicks is shown as directly holding 13,889 shares, which include shares to be issued upon the future vesting of one or more restricted stock units. The transaction reflects equity-based compensation rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 13,889 shares

Grant/Award 1 txn

Insider Wicks Timothy A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,889	$0.00	$0.00

Holdings After Transaction: Common Stock — 13,889 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units that vest on the one-year anniversary of the grant date.
2. F2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MiniMed (MMED) report for Timothy A. Wicks?

MiniMed reported that director Timothy A. Wicks received 13,889 shares of common stock via a grant of restricted stock units. This is a compensation-related equity award rather than an open-market stock purchase or sale.

How many shares did Timothy A. Wicks acquire in the latest MiniMed (MMED) Form 4?

Timothy A. Wicks acquired 13,889 shares of MiniMed common stock through a restricted stock unit grant. These shares are tied to vesting conditions and are not the result of an open-market transaction at a cash purchase price.

What are the vesting terms of Timothy A. Wicks’ restricted stock units at MiniMed (MMED)?

The filing states that the restricted stock units granted to Timothy A. Wicks vest on the one-year anniversary of the grant date. This means he must remain eligible through that period before the shares fully vest and become deliverable.

Are Timothy A. Wicks’ MiniMed (MMED) shares from this Form 4 directly owned?

Yes. The Form 4 lists Timothy A. Wicks’ ownership as direct, indicating the reported 13,889 shares are directly held. This total includes shares to be issued in connection with the vesting of one or more restricted stock units.

Does the MiniMed (MMED) Form 4 show any stock sales by Timothy A. Wicks?

No sales are reported in this Form 4. The filing only shows an acquisition via a grant of 13,889 restricted stock units, categorized as a grant, award, or other acquisition rather than a disposition of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wicks Timothy A

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		A		13,889(1)	A	$0	13,889(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest on the one-year anniversary of the grant date.

2. Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.